Research - Conference 2003 - Combating antibiotic resistance - European Conference on the role of research in combating antibiotic resistance - Rome, Italy, Friday 28

"Combating antibiotic resistance"
European Conference on the role of research in combating antibiotic resistance

Rome, Italy, Friday 28 - Sunday 30 November 2003

SCIENTIFIC PROGRAMME

Friday, 28 November 2003

OPENING ADDRESSES (15.00-16.00)

PLENARY LECTURES (16.00-18.30)

Chairpersons:

Roberta Fontana
Dipartimento di Patologia, Università degli Studi di Verona, Italy

Patrick Francioli
Div. Autonome de Médecine Préventive Hospitalière, CHUV, Lausanne, Switzerland

The biological basis for microbial spread: resistance and virulence of microbial pathogens and dissemination of successful antibiotic-resistant gram-positive clones in Europe
Marc Charles Enright
Department of Infectious Disease Epidemiology, Imperial College London, St. Mary's Hospital Campus, London, United Kingdom

Comparative resistance biology in gram-negative rods: mutations, gene transfer and clonal spread
Hajo Grundmann,
RIVM, Dept. of Infectious Diseases Epidemiology, Bilthoven, The Netherlands

Role of the pharmaceutical industry in promoting and funding antimicrobial research and prospects for the discovery and development of new antibiotics
André Bryskier
Aventis, Direction Recherches, Anti-Infectieux, Romainville, France

Interventions to control resistance: existing evidence and how to improve their scientific soundness
Peter Davey
MEMO, UK, Tayside Center for General Practice, University of Dundee, Dundee, United Kingdom

Our preparedness to meet the threat through non-antibiotic resources (alternative strategies, vaccines, etc)
Antonio Cassone
Dipartimento di Malattie Infettive, Parassitarie e Immunomediate, Istituto Superiore di Sanità, Rome, Italy

Saturday, 29 November 2003

PLENARY LECTURES (8:30 - 10:00)

Chairpersons:

Gian Carlo Schito
Istituto di Microbiologia, Università degli Studi di Genova, Italy

Carl Eric Nord
Huddinge University Hospital Department of Immunology, Microbiology, Pathology and Infectious Diseases, Huddinge, Sweden

Presentation of the newly funded FP6 projects
Anna Lönnroth
DG RTD/F-2, European Commission

The benefit of antibiotics and the risk of antibiotic resistance for human health: theoretical basis for a MONICA/Framingham-like long-term European Project
Fernando Baquero
Servicio de Microbiologia, Hospital Ramón y Cajal, Madrid, Spain

Six parallel workshops of max. 40 participants. Final conclusions drafted in the late afternoon-evening by each workshop rapporteur.

(Morning 10:00 to 12:00 and afternoon 13:30 to 16:30)

WG 1: Microbial population biology and ecology of resistance

Chairpersons:

Herman Goossens
Medical Microbiology, University Hospital UIA, Antwerp, Belgium

Stefania Stefani
Dip. di Scienze Microbiologiche e Ginecologiche, Univ. di Catania, Italy

Rapporteur:

Rafael Canton
Servicio de Microbiologia, Hospital Ramón y Cajal, Madrid, Spain

WG 2: The clonal spread of resistant bacteria in Europe

Chairpersons:

Gianni Pozzi
Dipartimento di Biologia Molecolare, Università degli Studi di Siena, Italy

Marc Struelens
Department of Microbiology, Université Libre de Bruxelles
Hopital Erasme, Bruxelles, Belgium

Rapporteur:

Vincent Jarlier
Laboratoire de Bactériologie, Groupe hospitalier Pitié-Salpétrière, Paris, France

WG 3: Antimicrobial drug discovery: exploitation of microbial genomics and of combinatorial chemistry for new molecular targets.

Chairpersons:

Achille Patrizio Caputi
Istituto di Farmacologia, Università di Messina, Italy

Ragnar Norrby
Swedish Institut for Infectious Disease Control, Solna, Sweden

Rapporteur:

Jordi Vila
Servicio de Microbiología, Hospital Clínic, Barcelona, Spain

WG 4: Clinical and epidemiological research for evaluating the outcome of antimicrobial-resistant infections.

Chairpersons:

Roberto Cauda
Clinica Malattie Infettive, Università Cattolica del Sacro Cuore, Rome, Italy

Roger Finch
Department of Infectious Diseases, The City Hospital, Nottingham, United Kingdom

Rapporteur:

Petra Gastmeier
Division of Hospital Epidemiology and Infection Control, Institute of Medical Microbiology and Hospital Epidemiology, Hanover, Germany

WG 5: Measures to control resistance by integrating microbiological, epidemiological and ecological research.

Chairpersons:

Stefania Salmaso
Centro nazionale di epidemiologia, sorveglianza e promozione della salute, Istituto Superiore di Sanità, Rome, Italy

Andreas Voss
Dept. of Med. Microbiology, University Medical Center St. Radboud, Nijmegen, The Netherlands

Rapporteur:

Annalisa Pantosti
Dipartimento di Malattie Infettive, Parassitarie e Immunomediate, Istituto Superiore di Sanità, Rome, Italy

WG 6: Research policy: how to advance antimicrobial resistance research and how to translate knowledge into novel solutions.

Chairpersons:

Giuseppe Cornaglia
Dipartimento di Patologia, Università degli Studi di Verona, Italy

Patrice Courvalin
Unité des Agents Antibactériens, Institut Pasteur, Paris, France

Rapporteur:

Roman Kozlov
Department of Clinical Pharmacology, Smolensk State Medical Academy, Russia

Sunday, 30 November 2003

PLENARY SESSION (8:30 - 10:00)

Chairpersons:

Patrick Francioli
Div. Autonome de Médecine Préventive Hospitalière, CHUV, Lausanne, Switzerland

Pietro Emanuele Varaldo
Istituto di Microbiologia, Università degli Studi di Ancona, Italy

Reports from the individual workgroups taking into account the issues that have been raised in the plenary sessions

Plenary discussion and conclusions

Closing remarks